ID   KLRA3_MOUSE             Reviewed;         266 AA.
AC   Q64329; Q3TWQ1; Q3ZB40; Q499I4; Q61154; Q61198; Q64257;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2012, sequence version 2.
DT   03-AUG-2022, entry version 169.
DE   RecName: Full=Killer cell lectin-like receptor 3;
DE   AltName: Full=5E6;
DE   AltName: Full=Lymphocyte antigen 49c;
DE            Short=Ly-49c;
DE   AltName: Full=Nk2.1;
DE   AltName: Full=T-cell surface glycoprotein Ly-49C;
GN   Name=Klra3; Synonyms=Ly-49c, Ly49C;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6 X CBA; TISSUE=Lung;
RX   PubMed=1869832;
RA   Wong S., Freeman J.D., Kelleher C., Mager D., Takei F.;
RT   "Ly-49 multigene family. New members of a superfamily of type II membrane
RT   proteins with lectin-like domains.";
RL   J. Immunol. 147:1417-1423(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ, C57BL/6 X BALB/c, C57BL/6J, CB-17/SCID, and NZB;
RX   PubMed=7629496; DOI=10.1084/jem.182.2.305;
RA   Stoneman E.R., Bennett M., An J., Chesnut K.A., Wakeland E.K.,
RA   Scheerer J.B., Siciliano M.J., Kumar V., Mathew P.A.;
RT   "Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed
RT   on a subset of murine natural killer cells.";
RL   J. Exp. Med. 182:305-313(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=C57BL/6J; TISSUE=Natural killer cell;
RX   PubMed=8976165; DOI=10.1084/jem.184.6.2085;
RA   Brennan J., Lemieux S., Freeman J.D., Mager D.L., Takei F.;
RT   "Heterogeneity among Ly-49C natural killer (NK) cells: characterization of
RT   highly related receptors with differing functions and expression
RT   patterns.";
RL   J. Exp. Med. 184:2085-2090(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=A/Sn, and C57BL/6J;
RX   PubMed=8892625;
RA   Sundbaeck J., Kaerre K., Sentman C.L.;
RT   "Cloning of minimally divergent allelic forms of the natural killer (NK)
RT   receptor Ly-49C, differentially controlled by host genes in the MHC and NK
RT   gene complexes.";
RL   J. Immunol. 157:3936-3942(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   MUTAGENESIS OF ASN-160; LYS-161; THR-162; ALA-169; ASN-170; HIS-173;
RP   TYR-174; ILE-195; PRO-196; LYS-225; ILE-226; ARG-234; ASP-248; ASN-250 AND
RP   ILE-251.
RX   PubMed=11777974; DOI=10.4049/jimmunol.168.2.793;
RA   Sundback J., Achour A., Michaelsson J., Lindstrom H., Karre K.;
RT   "NK cell inhibitory receptor Ly-49C residues involved in MHC class I
RT   binding.";
RL   J. Immunol. 168:793-800(2002).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 142-263 OF WILD-TYPE AND MUTANT
RP   ARG-121/SER-175/GLU-197/ARG-227 IN COMPLEX WITH H-2K, SUBUNIT, DISULFIDE
RP   BONDS, AND MUTAGENESIS OF ARG-121; SER-175; GLU-197 AND ARG-227.
RX   PubMed=14595439; DOI=10.1038/ni1006;
RA   Dam J., Guan R., Natarajan K., Dimasi N., Chlewicki L.K., Kranz D.M.,
RA   Schuck P., Margulies D.H., Mariuzza R.A.;
RT   "Variable MHC class I engagement by Ly49 natural killer cell receptors
RT   demonstrated by the crystal structure of Ly49C bound to H-2K(b).";
RL   Nat. Immunol. 4:1213-1222(2003).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 67-266 ALONE AND IN COMPLEX WITH
RP   H-2K, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=18426793; DOI=10.1074/jbc.m801526200;
RA   Deng L., Cho S., Malchiodi E.L., Kerzic M.C., Dam J., Mariuzza R.A.;
RT   "Molecular architecture of the major histocompatibility complex class I-
RT   binding site of Ly49 natural killer cell receptors.";
RL   J. Biol. Chem. 283:16840-16849(2008).
CC   -!- FUNCTION: Receptor on natural killer (NK) cells for class I MHC.
CC       {ECO:0000269|PubMed:8976165}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000269|PubMed:14595439,
CC       ECO:0000269|PubMed:18426793}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type II membrane protein.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10305; AAA19053.1; -; mRNA.
DR   EMBL; U09739; AAA86873.1; -; mRNA.
DR   EMBL; U49865; AAA92951.1; -; mRNA.
DR   EMBL; U49866; AAA92952.1; -; mRNA.
DR   EMBL; U49867; AAA92953.1; -; mRNA.
DR   EMBL; U49868; AAA92954.1; -; mRNA.
DR   EMBL; U56404; AAB19100.1; -; mRNA.
DR   EMBL; U56405; AAB19101.1; -; mRNA.
DR   EMBL; AK159595; BAE35215.1; -; mRNA.
DR   EMBL; AC087336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC099867; AAH99867.1; -; mRNA.
DR   EMBL; BC099878; AAH99878.1; -; mRNA.
DR   EMBL; BC099879; AAH99879.1; -; mRNA.
DR   EMBL; BC099880; AAH99880.1; -; mRNA.
DR   EMBL; BC101952; AAI01953.1; -; mRNA.
DR   EMBL; BC103543; AAI03544.1; -; mRNA.
DR   EMBL; BC103544; AAI03545.1; -; mRNA.
DR   EMBL; BC103545; AAI03546.1; -; mRNA.
DR   EMBL; BC132524; AAI32525.1; -; mRNA.
DR   EMBL; BC132526; AAI32527.1; -; mRNA.
DR   EMBL; BC145192; AAI45193.1; -; mRNA.
DR   EMBL; BC145193; AAI45194.1; -; mRNA.
DR   CCDS; CCDS20601.1; -.
DR   PIR; I49059; I49059.
DR   PIR; I49363; I49363.
DR   RefSeq; NP_001276533.1; NM_001289604.1.
DR   RefSeq; NP_001276534.1; NM_001289605.1.
DR   RefSeq; NP_034778.2; NM_010648.3.
DR   RefSeq; NP_034781.2; NM_010651.3.
DR   RefSeq; XP_011239535.1; XM_011241233.1.
DR   RefSeq; XP_011239537.1; XM_011241235.1.
DR   PDB; 1P1Z; X-ray; 3.26 A; D=143-262.
DR   PDB; 1P4L; X-ray; 2.90 A; D=142-263.
DR   PDB; 3C8J; X-ray; 2.60 A; A/B/C/D=67-266.
DR   PDB; 3C8K; X-ray; 2.90 A; D=142-266.
DR   PDB; 5J6G; X-ray; 3.30 A; G/H=136-266.
DR   PDBsum; 1P1Z; -.
DR   PDBsum; 1P4L; -.
DR   PDBsum; 3C8J; -.
DR   PDBsum; 3C8K; -.
DR   PDBsum; 5J6G; -.
DR   AlphaFoldDB; Q64329; -.
DR   SMR; Q64329; -.
DR   BioGRID; 200995; 1.
DR   STRING; 10090.ENSMUSP00000107629; -.
DR   GlyGen; Q64329; 5 sites.
DR   EPD; Q64329; -.
DR   PaxDb; Q64329; -.
DR   PRIDE; Q64329; -.
DR   DNASU; 16640; -.
DR   Ensembl; ENSMUST00000088017; ENSMUSP00000085333; ENSMUSG00000067591.
DR   Ensembl; ENSMUST00000111998; ENSMUSP00000107629; ENSMUSG00000067591.
DR   GeneID; 16634; -.
DR   GeneID; 16640; -.
DR   KEGG; mmu:16634; -.
DR   KEGG; mmu:16640; -.
DR   UCSC; uc009eik.2; mouse.
DR   CTD; 16634; -.
DR   CTD; 16640; -.
DR   MGI; MGI:101905; Klra3.
DR   VEuPathDB; HostDB:ENSMUSG00000067591; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00390000008117; -.
DR   HOGENOM; CLU_049894_1_0_1; -.
DR   InParanoid; Q64329; -.
DR   OMA; HDSAWID; -.
DR   OrthoDB; 945977at2759; -.
DR   PhylomeDB; Q64329; -.
DR   TreeFam; TF336674; -.
DR   BioGRID-ORCS; 16634; 1 hit in 40 CRISPR screens.
DR   BioGRID-ORCS; 16640; 1 hit in 39 CRISPR screens.
DR   ChiTaRS; Klra3; mouse.
DR   EvolutionaryTrace; Q64329; -.
DR   PRO; PR:Q64329; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; Q64329; protein.
DR   Bgee; ENSMUSG00000067591; Expressed in spleen and 11 other tissues.
DR   Genevisible; Q64329; MM.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:MGI.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   CDD; cd03593; CLECT_NK_receptors_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR013600; Ly49_N.
DR   InterPro; IPR033992; NKR-like_CTLD.
DR   Pfam; PF00059; Lectin_C; 1.
DR   Pfam; PF08391; Ly49; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell adhesion; Disulfide bond; Glycoprotein; Lectin;
KW   Membrane; Receptor; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..266
FT                   /note="Killer cell lectin-like receptor 3"
FT                   /id="PRO_0000046681"
FT   TOPO_DOM        1..48
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        49..69
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        70..266
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          150..258
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          147..151
FT                   /note="Involved in dimerization"
FT   REGION          160..162
FT                   /note="Implicated in MHC class I binding"
FT   REGION          195..196
FT                   /note="Implicated in MHC class I binding"
FT   REGION          207..208
FT                   /note="Implicated in MHC class I binding"
FT   REGION          224..233
FT                   /note="Implicated in MHC class I binding"
FT   REGION          240..245
FT                   /note="Implicated in MHC class I binding"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        87
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        113
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        160
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        149..154
FT   DISULFID        167..255
FT   DISULFID        171..257
FT   DISULFID        236..249
FT   VARIANT         2
FT                   /note="S -> N (in strain: C57BL/6 and C57BL/6 XBALB/c)"
FT   VARIANT         22
FT                   /note="L -> Q (in strain: A/Sn, BALB/c, C57BL/6, C57BL/6
FT                   XBALB/c, C57BL/6 XCBA, CB-17/SCID and NZB)"
FT   VARIANT         34
FT                   /note="V -> A (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         41..42
FT                   /note="AP -> VS (in strain: C57BL/6 XBALB/c, NZB and
FT                   C57BL/6)"
FT   VARIANT         60
FT                   /note="T -> I (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         65..66
FT                   /note="AV -> TI (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         72
FT                   /note="N -> S (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         85
FT                   /note="H -> Y (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         93..94
FT                   /note="RA -> SD (in strain: A/Sn, BALB/c, C57BL/6, C57BL/6
FT                   XBALB/c, C57BL/6 XCBA, CB-17/SCID and NZB)"
FT   VARIANT         115
FT                   /note="T -> L (in strain: C57BL/6, C57BL/6 XBALB/c and NZB;
FT                   requires 2 nucleotide substitutions)"
FT   VARIANT         117
FT                   /note="E -> D (in strain: C57BL/6 and C57BL/6 XBALB/c)"
FT   VARIANT         127
FT                   /note="D -> N (in strain: C57BL/6 and C57BL/6 XBALB/c)"
FT   VARIANT         129
FT                   /note="K -> E (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         131
FT                   /note="K -> N (in strain: NZB)"
FT   VARIANT         133
FT                   /note="V -> I (in strain: NZB)"
FT   VARIANT         146
FT                   /note="Y -> H (in strain: C57BL/6 and C57BL/6 XBALB/c)"
FT   VARIANT         151
FT                   /note="S -> G (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         174
FT                   /note="Y -> F (in strain: A/Sn, BALB/c, C57BL/6, C57BL/6
FT                   XBALB/c, C57BL/6 XCBA, CB-17/SCID and NZB)"
FT   VARIANT         179
FT                   /note="L -> V (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         189
FT                   /note="F -> S (in strain: NZB)"
FT   VARIANT         198
FT                   /note="N -> S (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         219
FT                   /note="P -> Q (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         226
FT                   /note="I -> T (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         232
FT                   /note="K -> T (in strain: NZB)"
FT   VARIANT         247
FT                   /note="I -> T (in strain: C57BL/6, C57BL/6 XBALB/c and
FT                   NZB)"
FT   VARIANT         251
FT                   /note="I -> T (in strain: NZB)"
FT   VARIANT         260
FT                   /note="K -> R (in strain: NZB)"
FT   MUTAGEN         121
FT                   /note="R->G: Increases stability and improves binding to
FT                   MHCI class ligand; when associated with G-175; G-197 and
FT                   K-227."
FT                   /evidence="ECO:0000269|PubMed:14595439"
FT   MUTAGEN         160
FT                   /note="N->D: Greatly reduces MHC class I peptide tetramer
FT                   binding; when associated with L-162."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         161
FT                   /note="K->R: No effect on MHC class I peptide tetramer
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         162
FT                   /note="T->K: Greatly reduces MHC class I peptide tetramer
FT                   binding; when associated with D-160."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         169
FT                   /note="A->Q: No effect on MHC class I peptide tetramer
FT                   binding; when associated with T-170."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         170
FT                   /note="N->T: No effect on MHC class I peptide tetramer
FT                   binding; when associated with Q-169."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         173
FT                   /note="H->S: No effect on MHC class I peptide tetramer
FT                   binding; when associated with S-174."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         174
FT                   /note="Y->S: No effect on MHC class I binding; when
FT                   associated with S-173."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         175
FT                   /note="S->G: Increases stability. Increases stability and
FT                   improves binding to MHCI class ligand; when associated with
FT                   G-121; G-197 and K-227."
FT                   /evidence="ECO:0000269|PubMed:14595439"
FT   MUTAGEN         195
FT                   /note="I->P: Greatly reduces MHC class I peptide tetramer
FT                   binding; when associated with S-196."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         196
FT                   /note="P->S: Greatly reduces MHC class I peptide tetramer
FT                   binding; when associated with P-195."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         197
FT                   /note="E->G: Increases stability and improves binding to
FT                   MHCI class ligand; when associated with G-121; G-175 and
FT                   K-227."
FT                   /evidence="ECO:0000269|PubMed:14595439"
FT   MUTAGEN         225
FT                   /note="K->N: Greatly reduces MHC class I peptide tetramer
FT                   binding; when associated with T-226."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         226
FT                   /note="I->T: Greatly reduces MHC class I peptide tetramer
FT                   binding; when associated with N-225."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         227
FT                   /note="R->K: Increases stability and improves binding to
FT                   MHCI class ligand; when associated with G-121; G-175 and
FT                   G-197."
FT                   /evidence="ECO:0000269|PubMed:14595439"
FT   MUTAGEN         234
FT                   /note="R->G: No effect on MHC class I peptide tetramer
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         248
FT                   /note="D->N: No effect on MHC class I peptide tetramer
FT                   binding; when associated with D-250."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         250
FT                   /note="N->D: No effect on MHC class I peptide tetramer
FT                   binding; when associated with N-248."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   MUTAGEN         251
FT                   /note="I->Q: No effect on MHC class I peptide tetramer
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:11777974"
FT   CONFLICT        4
FT                   /note="P -> L (in Ref. 7;
FT                   AAH99880/AAH99879/AAH99878/AAH99867)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="T -> M (in Ref. 5; BAE35215)"
FT                   /evidence="ECO:0000305"
FT   STRAND          145..151
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          153..162
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   HELIX           164..173
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   HELIX           184..193
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          199..206
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   TURN            207..210
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          211..214
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   HELIX           223..227
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          233..239
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          244..247
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          253..260
FT                   /evidence="ECO:0007829|PDB:3C8J"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:3C8J"
SQ   SEQUENCE   266 AA;  31311 MW;  BF9B10D9B6EFD628 CRC64;
     MSEPEVTYST VRLHKSSGLQ KLVRHEETQG PREVGNRKCS APWQLIVKAL GILCFLLLVT
     VAVLAVKIFQ YNQHKQEINE TLNHHHNCSN MQRAFNLKEE MLTNKSIDCR PSNETLEYIK
     REQDRWDSKT KTVLDSSRDT GRGVKYWFCY STKCYYFIMN KTTWSGCKAN CQHYSVPILK
     IEDEDELKFL QRHVIPENYW IGLSYDKKKK EWAWIDNGPS KLDMKIRKMN FKSRGCVFLS
     KARIEDIDCN IPYYCICGKK LDKFPD
//
